Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia
Clinical trial NCT04674345 · UNKNOWN
Trial details
- NCT number
- NCT04674345
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-12-31
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.